摘要
目的:探讨心脏手术后产妇的分娩方式、抗凝剂的应用。方法:对13例心脏手术后孕妇分娩的资料进行回顾性分析。结果:心脏手术后心功能Ⅰ~Ⅲ级,心脏手术后1年半以上可以妊娠并安全渡过孕产期;妊娠期口服华法令及分娩期应用肝素未增加母婴出血及新生儿畸形。结论:心脏瓣膜置换术者采用手术产为宜,二尖瓣球囊扩张术者以阴道分娩为宜。心脏手术后分娩前心功能达到Ⅰ~Ⅲ级、服用强心剂达到Ⅱ~Ⅲ级者,可安全分娩;妊娠期依据凝血酶原值服用抗凝剂,不增加分娩并发症。
Objective:Tostudythecardiacfunction,modeofdeliveryandanticoagulanttherapyin13pregnantwomenaftercardiacvalvesreplacement(CVR)andpercutaneoustransluminalmitralcommissuroplasty(PTMC).Method:Retrospectivedataanalysis.Results:PatientswithcardiacfunctionofdegreeItoIIcanaccomplishpregnancyanddeliverysafelyaftercardiacoperationoneandahalfyears.Usingwarfarinduringpregnancyanddeliverysafely.Usingwarfarinduringpregnancyandheparinduringdeliverydidnotincreasethebloodlossinbothmothersandneonates,andcongen-italmalformationeither.ItismoreappropriateforpregnantwomenwhohadCVRtodeliverbyce-sareansectionandthosewhohadPTMCtodelivervaginaly.Conclusions:Womenaftercardiacop-erationcanaccomplishpregnancyanddeliveryiftheircardiacfunctionbelongtodegreeI~IIwithorwithoutdigoxintreatmentbeforedelivery.Usinganticoagulanttherapycorrectlyaccordingtopro-thrombintime(PT)testduringpregnancydoesnotincreasedeliverycomplicationstobothmothersandneonates.
出处
《中华妇产科杂志》
CAS
CSCD
北大核心
1996年第1期12-14,共3页
Chinese Journal of Obstetrics and Gynecology